We have the 2008 Annual Report, complete with leadership teams, available as an electronic download (pdf)
We have the 2008 Annual Report, complete with leadership teams, available as an electronic download (pdf)
Mark down 2008 as a year of achievement and advancement in ensuring that all educational programs at the Medical Center are nationally outstanding and prepare students for careers of excellence — one of the seven primary goals of the Medical Center’s Strategic Plan.
It was a year when the School of Medicine and Dentistry received maximum national accreditation, but still conducted an internal critical review of the highly respected Double Helix curriculum that resulted in the creation of a significant new course. During the year, the School also began incorporating “Domains of Excellence” — objectives that parallel the Accreditation Council for Graduate Medical Education’s competencies required for medical residents — into the curriculum for medical students, a preparation for a career of lifelong learning.
It was a year of new deans for the School of Nursing and for the School of Medicine and Dentistry’s graduate programs. Kathy P. Parker, Ph.D., R.N., F.A.A.N., plans to increase enrollment at the School of Nursing. Her goals include transforming nursing practice through clinical and research activities while working collaboratively with the Medical Center to achieve patient safety, quality and satisfaction. Edith Lord, Ph.D., plans to expand the diversity of students in the School of Medicine and Dentistry’s graduate program.
In another step in educational excellence, the School introduced new degree programs in translational science and linked with medical schools in Spain and Peru for student exchanges.
And in 2008, the dean of the School of Medicine and Dentistry and a longtime faculty member were elected to the Institute of Medicine, a distinct mark of excellence.
In April 2008, the Liaison Committee on Medical Education (LCME) affirmed that the School of Medicine and Dentistry is achieving the goal of continuing excellence, awarding the School high praise and a full eight-year accreditation.
The award followed almost two years of rigorous review. The LCME survey team visited the School for personal interviews and evaluation in the fall of 2007. Fifteen months before the site visit, a task force of more than 80 faculty members began a self-evaluation of the School for the LCME. The report addressed more than 130 standards and many topics prescribed by the LCME. The School’s students also developed and presented an independent evaluation to the LCME.
In granting the maximum accreditation, the LCME cited the School of Medicine and Dentistry’s culture of collegiality, connectedness and collaboration. In listing the School’s strengths, the LCME described the Double Helix curriculum as a successful longitudinal integration of the basic and clinical sciences and highlighted several programs as innovative elements of the curriculum, including the basic science blocks in the third year, the Process of Discovery basic science course and the Community Health Improvement Course (CHIC) in the fourth year.
The LCME called the depth and breadth of the School’s research enterprise exemplary and commended the School for providing students with numerous opportunities, and often financial and logistical support, to pursue areas of special interest beyond the standard curriculum, such as international health experiences. The Comprehensive Assessments for second-year and third-year students are successful examples of formative assessments that give students the opportunity to identify their learning needs, develop an individualized learning plan and receive follow-up to make sure those needs are met, according to the LCME accreditation report. The LCME cited David S. Guzick, M.D., Ph.D., the School’s dean, for outstanding leadership and a commitment to medical education and medical students, and said David R. Lambert, M.D., associate dean for undergraduate medical education, devotes great amounts of time, effort and energy to implement the School’s educational vision and mission.
While the maximum accreditation is a significant accomplishment, it was no reason to stand still.
After accreditation was awarded, the School of Medicine and Dentistry conducted a review of the overall curriculum that affirmed the strength of the Double Helix curriculum. The Curriculum Steering Committee endorsed the creation of a 10-week course in the first year called “Skills in Complete Patient Evaluation (SCOPE)” that will involve students in health care in chronic care facilities, nursing homes and rehabilitation facilities. The new course, which will begin in January 2010, is another example of the School’s philosophy of exposing students to various disciplines early in their medical education. Additionally, the School increased the surgery clerkship in the third year from five to six weeks, with two of the weeks dedicated to subspecialty or community general surgery. This takes effect in July. In August, the School launches a new computerized examination system.
The School of Medicine and Dentistry also has moved forward on a specific goal cited in the strategic plan , a curriculum initiative identifying “Domains of Excellence” that parallel the Accreditation Council for Graduate Medical Education’s competencies required for medical residents.
The competencies — scientific knowledge, patient care skills, communication, professionalism, evidence-based medicine and systems-based quality and safety — go beyond setting minimum requirements for medical knowledge and patient care skills to define what makes a well-rounded, effective physician who is equipped with the ability to keep up with changes in the profession.
Medical schools are required to develop curriculums for residents that address the competencies, to assess residents on their level of achievement of the competencies and to use data to continually improve programs for residents.
The School of Medicine and Dentistry is establishing educational objectives for each of the six domains that will be present throughout the curriculum for medical students. These objectives will contribute to the comprehensive education of Rochester medical students and prepare students for residency education and lifelong learning.
So far, the School has evaluated the curriculum to make sure it meets the objectives for scientific knowledge, patient-care skills and professionalism.
After a national search, the School of Nursing welcomed Kathy P. Parker , Ph.D., R.N., F.A.A.N., an accomplished nursing professional with a profile of success as an educator, clinician, researcher and leader, as the School’s fourth dean.
A nationally recognized sleep disorders researcher, Parker previously served as the Edith F. Honeycutt Professor of Nursing in the Department of Family and Community Nursing at Emory University’s Nell Hodgson Woodruff School of Nursing in Atlanta.
Top among her goals as dean is increasing enrollment in targeted programs, specifically the accelerated programs for non-nurses, and the master’s, doctor of nursing practice and Ph.D. programs. Parker also plans strategic recruitment of faculty, based on key existing and potential research clusters. Her other objectives include transforming nursing practice through clinical and research activities while working collaboratively with the Medical Center to achieve patient safety, quality and satisfaction goals. She also will encourage faculty practice.
Enhancing the School of Nursing’s reputation nationally and increasing NIH funding and rank are high priorities for the new dean.
With more than 20 years of clinical practice experience, Parker is certified by the American Nursing Credentialing Center as both an adult nurse practitioner and clinical specialist in adult health. She brings a national reputation in research and a record of substantial NIH funding and is one of five nurses in the country certified in Clinical Sleep Disorders.
Parker received her undergraduate degree in nursing from Columbia University, her master’s in nursing from Emory University, and her doctorate in nursing from Georgia State University. She is a member of numerous professional organizations, and has served on the Institute of Medicine’s Committee on Sleep Medicine and Research. She is a fellow of the American Academy of Sleep Medicine and the American Academy of Nursing, and has over 100 journal articles, abstracts and proceedings to her credit.
Parker succeeds Dean Patricia A. Chiverton, E.D., R.N., F.N.A.P., whose eight-year tenure was marked by a number of innovations, including the launch of new academic programs and an $8.1 million renovation and expansion project.
The School of Medicine and Dentistry educates scientists and researchers as well as physicians. In a time of constrained national support for research, a new dean will lead this vitally important school program.
In July 2008, Edith Lord, Ph.D., professor of Microbiology and Immunology and of Oncology at the School of Medicine and Dentistry, became the School’s senior associate dean for graduate education. A faculty member for 30 years, Lord will direct the School of Medicine and Dentistry’s Ph.D., postdoctoral and master’s degree programs, which have about 800 students enrolled. She succeeds Paul L. LaCelle, M.D., who returns to full-time research in the Department of Biomedical Engineering.
Her goals include “building on the strong legacy of Dr. LaCelle to further strengthen the size and quality of our graduate program,” developing a postdoctoral office to provide support and guidance for fellows and increasing the diversity of the graduate class, Lord said. She already has initiated a redesign of the graduate program’s Web site to make it a more attractive and user-friendly portal for potential students. She also plans to develop new courses to assist the career objectives of students and faculty.
Lord will continue her research. She focuses on the immune responses that can control tumor development and also studies the unique microenvironment present within growing tumors. Lord has published, as author or co-author, more than 100 scientific articles.
A Phi Beta Kappa graduate of the University of Kansas, Lord received a Ph.D. in biology from the University of California at San Diego. She was a postdoctoral fellow at the University of California at San Francisco. She joined the School of Medicine and Dentistry faculty as a senior instructor in 1976. She was named assistant professor in 1978, associate professor in 1984 and professor in 1994.
Another primary goal of the strategic plan is to ensure translation of fundamental discovery into cutting-edge patient therapies through the education of clinicians and scientists.
The School took an important step toward that goal in December 2007 when the New York State Department of Education approved the School of Medicine and Dentistry’s new Ph.D. in Translational Biomedical Science. The new degree program is an outgrowth of a proposal in the School of Medicine and Dentistry’s initial Clinical and Translational Science Award application. The doctorate emphasizes basic science foundations and provides dual basic and clinical scientist mentoring/advising and extensive flexibility for students to follow their interests in translational research.
A new certificate program is being developed for Ph.D. students to enable them to take necessary translational science courses along with their regular coursework so that they have the basic knowledge and some experience during their Ph.D. program. The School of Medicine and Dentistry also offers a Master of Science in Clinical Investigation that focuses on clinical and population based research training for investigators with prior clinical training or for those enrolled in a clinical training program. The primary objective of this program is to train individuals to combine clinical knowledge and population-based research in an academic program that awards a recognized credential indicating expertise in clinical epidemiology, research study design, clinical decision-making, and the evaluation of health care services. Planning also is under way for a Master of Science in Translational Research. This program will focus on multidisciplinary research skills needed to carry out bench to bedside translational research.
A new specialization within the current Master of Science in Teaching and Curriculum program is being offered to doctors, nurses and other health care professionals who want to teach or who want to expand their educational skills.
The degree program is designed for faculty in a school of medicine, dentistry or nursing, health professionals, such as registered nurses, physicians, pharmacists or physical therapists, who teach or train new members of their field, and practitioners who teach patients or clients health promotion.
The program was developed through a unique collaboration of the University’s Warner School of Education, the School of Nursing and the School of Medicine and Dentistry. Faculty from each of the three schools will teach courses offered in the
master’s program. The University is the first in the area to offer a comprehensive master’s degree program in health professions education. The University of Toronto and the University of Pittsburgh are the closest institutions with similar programs.
Requirements of the degree, which can be earned in one year of full-time study, include 30 credit hours and a master’s essay. Two core courses, specifically created for the new degree, address health care education issues and teaching methods. With only five required courses, the program allows a wide choice of electives and independent study.
The School of Nursing is among the first institutions in the nation to receive funding from the Robert Wood Johnson Foundation (RWJF) to provide scholarships for people with bachelor’s degrees in other fields who wish to pursue careers in nursing. Grants provided through the competitive RWJF New Careers in Nursing Scholarship Program will be used for scholarships to increase the number of students enrolled in The School of Nursing’s accelerated baccalaureate and master’s programs for non-nurses (APNN), which build upon students’ existing degrees by providing generalist nursing studies that qualify students for their nursing licensing exams.
This groundbreaking national initiative, launched by RWJF and the American Association of Colleges of Nursing (AACN), aims to help alleviate the nation’s nursing shortage by dramatically expanding the pipeline of students in accelerated nursing programs. The School of Nursing was awarded $150,000, which will provide $10,000 scholarships for 15 students.
The School’s accelerated programs for non-nurses opened in 2002 with a class of 22 full-time students and has grown significantly, with a current class size of 100 full-time students.
By bringing more nurses into the profession at the baccalaureate and master’s degree levels, the new scholarship program also helps to address the nation’s nurse faculty shortage. Data from the U.S. Health Resources and Services Administration show that nurses entering the profession at the baccalaureate level are four times more likely than other nurses to pursue a graduate degree in nursing, which is the required credential to teach.
Additionally, the program targets the need to recruit students from groups underrepresented in nursing or disadvantaged backgrounds. According to the National Advisory Council on Nurse Education and Practice, diversifying the nursing profession is essential to meeting the health care needs of the nation and reducing health disparities that exist among many under-served populations.
In response to the overwhelming need to safely and expeditiously bring drugs, vaccines and medical devices to the people who need them, the School of Nursing launched a comprehensive training course aimed at giving nurses and other health care professionals the education they need to manage clinical trials. A critical step in moving medical advances from the research phase to the marketplace, clinical trials are run by researchers and principal investigators, but often managed by individuals with little or no formal training in clinical trials research.
“Managing Clinical Trials: A Comprehensive Continuing Education Course for Healthcare Professionals” focuses on the structure, regulation, and financing of the clinical trials industry, aspects of the pharmaceutical development process, ethics and regulations of clinical trials, study implementation, data collection and management, patient recruitment, and study conclusion. The School partnered with Global Research Services, LLC, an international contract research organization with an established history in clinical trials research, to provide students with expert faculty and comprehensive curriculum. The course is a 40-hour, Web-based, interactive program delivered in an online learning format.
The School of Medicine and Dentistry expanded its international reach in 2008. The School entered into formal exchange agreements with Universidad Nacional Mayor de San Marcos in Peru, and with Clinica Universitaria de la Universidad de Navarra in Spain.
Medical students in their final years at the schools will attend the School of Medicine and Dentistry for 12 weeks of clinical electives. The exchange program exposes the students to American medical practices and enables Rochester students to work with students from other countries and cultures.
The School now has five formal exchange agreements in a program that includes the University of Wuerzberg in Germany, Jagiellonian University in Poland, and National Taiwan University. Forty-three students from the five schools take part in the exchange each year.
The strategic plan sets a goal of achieving national recognition for our high quality signature programs. There are very few honors denoting national recognition that are more significant than election to the Institute of Medicine (IOM).
David S. Guzick, M.D., Ph.D., dean of the University of Rochester School of Medicine and Dentistry, professor of Obstetrics and Gynecology and the director of the University’s Clinical and Translational Science Institute, and Ira Shoulson, M.D., a neurologist who has pioneered research methods that have led to new treatments for Huntington’s disease, Parkinson’s disease and other neurodegenerative illnesses, have been elected to the IOM, one of the most prestigious honors in the fields of medicine and health.
No more than 65 new members are elected annually to the IOM. The number of active members is about 1,600. The University now has 16 faculty members or emeritus faculty in the institute.
Bradford C. Berk, M.D., Ph.D., chief executive officer of the University of Rochester Medical Center, said election to the IOM is a “career highlight.
“Many aspire to the Institute of Medicine, not only because it represents national recognition by your colleagues, but because the IOM issues reports that determine the direction of future health policy,” Berk said. “David Guzick and Ira Shoulson have the leadership and vision to participate in the planning for future health care, and we take great pride in their election.”
Guzick said he is “extremely humbled by this honor, especially because clinical research is always a collaborative effort.
“My achievements reflect the profound influence of my clinical and research mentors, my collaborators, and the altruism of the many women and men who volunteered to participate in the research studies that my colleagues and I have conducted,” he said.
Shoulson, who is the Louis C. Lasagna Professor of Experimental Therapeutics and professor of Neurology, Pharmacology and of Medicine, shared a similar reaction to his election.
“I am especially honored because my contributions represent the work of hundreds of colleagues who engage in cooperative clinical research. My election is a fitting recognition of the group, in addition to the individual honor,” he said. “I am buoyed by the fact that my achievements derive in large part from the dedicated work of my colleagues around the world in the Parkinson Study Group and Huntington Study Group, as well as the thousands of research participants who participate in our multi-center clinical trials.”
An independent Department of Physical Medicine and Rehabilitation (PM&R) was established at the School of Medicine and Dentistry in April, a tribute to the critical role physiatrists, physical therapists and occupational therapists play in helping patients recover from sudden illness and trauma. Led by K. Rao Poduri, M.D., the department formerly was a division within the Department of Orthopaedics.
Over the past four years, PM&R has demonstrated its clinical strength at Strong Memorial Hospital, growing inpatient visits by 10 percent, and quadrupling its outpatient visits. Today, 16 board-certified physiatrists provide a wide spectrum of specialty services in the Rochester community, such as management of the complex rehabilitation needed to help stroke and spinal cord patients live as independently as possible.
Faculty oversee rehabilitation care at Strong Memorial, Unity Hospital’s St. Mary’s campus, Rochester General Hospital and the Veterans Administration Medical Center in Canandaigua. In addition, 125 allied health care professionals at Strong Memorial alone provide rehabilitation therapy services to the Rochester community.
PM&R is accredited for adults and pediatric patients by the Commission for Accreditation of Rehabilitation Facilities for its general rehab program, stroke program and the spinal cord injury system of care. It has achieved the highest level of accreditation that can be awarded to an organization in the field. The department also has made great strides in establishing one of the most successful residency training programs in the nation. Due to increased demand, the number of resident positions in PM&R has doubled to 12 since 2004. Research grants continue to grow as well, with five funded studies and many others in progress.
Latha G. Stead, M.D., became professor and chair of the Department of Emergency Medicine January 1. She had been chair of the Division of Emergency Medicine Research at the Mayo Medical School in Minnesota.
Stead replaces Sandra M. Schneider, M.D., who headed the department for 14 years before stepping down to devote time to her expanding responsibilities at several national emergency medicine organizations.
In her new position, Stead will manage operations at Strong Memorial Hospital’s Emergency Department, the state’s busiest department outside of the New York City metropolitan area, logging more than 95,000 patients annually. In addition to her responsibilities as chief of service for the emergency department at Strong, Stead will be charged with further developing the research and educational missions of the department. Stead’s connection to Rochester dates back to her undergraduate studies. She earned a bachelor’s degree in biochemistry from the University’s College of Arts and Sciences in 1990.
He follows Robert “Berch” Griggs, M.D., who has led the department since 1986. During Griggs’ tenure, yearly research funding in the department skyrocketed from about $1 million to approximately $28 million, and faculty size quadrupled. Griggs is continuing as professor of neurology, and will serve as president of the American Academy of Neurology, the nation’s largest professional organization of neurologists.
Goldman is internationally recognized for advancing the understanding of stem cells and their use to treat human disease. He has created new ways to isolate stem cells and then re-create the molecular signals that direct their development as part of research that aims to use the cells to treat a variety of conditions, including Parkinson’s and Huntington’s diseases.
At Rochester, Goldman will continue as chief of the department’s Division of Cell and Gene Therapy and as professor of Neurological Surgery.
Denham Ward, M.D., Ph.D., professor of Biomedical Engineering and of Anesthesiology, and former chair of the Department of Anesthesiology, returned as chair of the department for a three-year term in August. He succeeds James Robotham, M.D., who stepped down to focus on his research. An internationally recognized expert in the field of anesthesiology, Ward was recruited to Rochester in 1992 to lead the Department of Anesthesiology, a position he held for close to a decade. Ward stepped down as chair in 2001, and while on sabbatical at the University of Leiden in the Netherlands, continued his study on the control of breathing, and also edited a book, Pharmacology and Pathophysiology of the Control of Breathing.
In 2006, Ward was named associate dean for faculty development-medical education, charged with developing programs and training sessions to improve faculty teaching skills at the School of Medicine and Dentistry. He will continue in this role.
Susan Gross Fisher, M.S., Ph.D., became chair of the Department of Public Health Sciences. An accomplished researcher and expert in cancer epidemiology, Fisher has been serving as interim chair of the department since July 2007. She succeeds Thomas Pearson, M.D., M.P.H., Ph.D., senior associate dean for clinical research, who led the department during the past decade through a period of tremendous growth. Pearson has returned from a sabbatical as a visiting scientist at the National Human Genome Research Institute.
Prior to her appointment, Fisher served as associate chair for research, director of the doctoral program for epidemiology, and division chief of epidemiology in the Department of Public Health Sciences. New York state approved a doctoral program in epidemiology at Rochester that was developed by Fisher. In addition, Fisher is an independent National Institutes of Health investigator, with a research focus on viral etiologies of cancer.
The Center for Oral Biology consists of several interdisciplinary research teams, which integrate and blend aspects of biochemistry, developmental biology, genetics, immunology, microbiology, physiology, pharmacology and structural biology to explore important problems of craniofacial, dental and oral biology. For almost 75 years, the University has trained dentists and other qualified individuals for academic careers in research related to oral health and disease.
Quivey’s research focuses on Streptococcus mutans and seeks to identify key genes and proteins that, if interfered with, can take away the ability of the bacteria to thrive in the mouth and cause tooth decay.
The center, which brings together a broad array of physicians and scientists, targets a complex system rather than a single disease. Center researchers investigate stroke, traumatic brain injury, brain tumors, nerve injuries, HIV-1 associated neurologic disorders, Alzheimer’s and other diseases with the goal of creating treatments and therapies.
Neuromedicine is one of the signature programs of the Medical Center’s 2007-2012 Strategic Plan, which aims to build on the Medical Center’s already strong position as a world leader in the prevention and treatment of these diseases. In the future, Gelbard expects the center to increase its focus on genetics and regenerative medicine. Three new investigators could be added in the next two years to the center.
Gelbard is an internationally recognized expert in HIV-related dementia.
Berislav Zlokovic, M.D., Ph.D., Dean’s Professor and professor of neurosurgery and neurology, was appointed director of the Center for Neurodegenerative and Vascular Brain Disorders.
The Center for Neurodegenerative and Vascular Brain Disorders focuses on studies of neuronal and vascular mechanisms in Alzheimer’s disease (AD) and other chronic neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson’s disease (PD), Huntington’s disease (HD) and others, as well as on brain ischemia and neuroprotection mechanisms in stroke. A key center priority is the development of new pre-clinical therapeutic approaches and the identification of novel targets for intervention in AD as well as in ALS, MS, PD, HD and stroke.
Steven Goldman, M.D., Ph.D., the Edward A. and Alma Vollertsen Rykenboer Professor of Neurophysiology and chair of the Department of Neurology, and Maiken Nedergaard, M.D., D.M.Sc., professor of Neurosurgery and of Neurobiology and Anatomy, were named co-directors of the Center for Translational Neuromedicine.
The center, through the Division of Cell and Gene Therapy, leads a pioneering effort in stem cell biology of the central nervous system (CNS) that is pointed towards therapeutic application in a variety of conditions. Center researchers are playing leading roles in understanding the underlying principles of neurogenesis in the adult nervous system, in the development of cellular therapies for pediatric disorders in which normal myelination is compromised, for adult disorders such as Parkinson’s disease and Huntington’s disease and also for treatment of spinal cord injury.
Researchers are also working in the field of cancer research to provide new insights into the cellular origin and potential treatment of tumors of the central nervous system.
The Division of Glial Disease and Therapeutics is focusing on the basic biology of glial cells in the CNS and the role of astrocytes in several neurological diseases, including stroke, spinal cord injury, epilepsy, tremor, and ALS. The research is aimed at defining new strategies for the treatment of neurological diseases that target astrocytic dysfunction.
Diane M. Hartmann, M.D., the School of Medicine and Dentistry’s senior associate dean for graduate medical education and professor of Obstetrics and Gynecology, was named by the Accreditation Council for Graduate Medical Education (ACGME) a recipient of the organization’s Parker J. Palmer Courage to Lead Award. She is one of three officials nationwide who will receive the award. The Palmer award is given annually to officials who have created an exemplary environment for educational programs, facilitated residents’ ethical, professional and personal development, and ensured safe and appropriate care of patients. The recipients are selected from a small community hospital, a large community hospital or a tertiary academic center.
In 2008, Hartmann also took over as chairperson of the Council on Resident Education in Obstetrics and Gynecology (CREOG). CREOG, a council of the American College of Obstetricians and Gynecologists, is dedicated to the promotion and maintenance of excellence in residency and subspecialty fellowship education.
Donald R. Bordley, M.D., associate chair of medicine, professor of Medicine and director of the Categorical Internal Medicine Residency program at the School of Medicine and Dentistry, served as president of the Association of Program Directors in Internal Medicine (APDIM) in 2008. With a membership of more than 1,900 individuals from 377 medical schools and teaching hospitals, APDIM represents nearly all of the accredited Internal Medicine residency programs in the United States, Puerto Rico, and Canada.
Bordley is the first William L. Morgan Professor in Medicine at the School, an endowed professorship named after a longtime Rochester faculty member and author of The Clinical Approach to the Patient, the influential textbook that has had a humanizing effect on medical teaching.
Ying Xue, D.N.Sc., R.N., assistant professor of Nursing, was one of 15 junior faculty nationwide to receive an inaugural Robert Wood Johnson Foundation Nurse Faculty Scholar (NFS) award. The three-year, $350,000 grant will support Xue’s research to examine national employment patterns of supplemental nurses in the U.S. from 1984 to 2004, one of the keys to understanding how to address the nursing shortage and further examine the impact of hospital supplemental
nurse staffing on quality of care and cost in an acute-care setting.
The goal of the Robert Wood Johnson Foundation Nurse Faculty Scholars program is to develop the next generation of national leaders in academic nursing through career development awards for outstanding junior nursing faculty. The program aims to strengthen the academic productivity and overall excellence of nursing schools by providing mentorship, leadership training, salary and research support to young faculty.
Nicholas Braus, a member of the School of Medicine and Dentistry Class of 2010, received a Doris Duke Charitable Foundation Clinical Research Fellowship to conduct research at the University of Iowa on the effects of helminthic infection on immune homeostasis in the gut.
David Perlmutter, a member of the School of Medicine and Dentistry Class of 2009, received a Howard Hughes Medical Institute (HHMI) Research Training Fellowship. He works in the laboratory of Berislav Zlokovic, M.D., Ph.D., professor of neurosurgery and of neurology. His project focuses on the interaction between altered glucose metabolism and blood brain barrier dysfunction in Alzheimer’s disease.